259 related articles for article (PubMed ID: 19996292)
21. TGFbeta/BMP type I receptors ALK1 and ALK2 are essential for BMP9-induced osteogenic signaling in mesenchymal stem cells.
Luo J; Tang M; Huang J; He BC; Gao JL; Chen L; Zuo GW; Zhang W; Luo Q; Shi Q; Zhang BQ; Bi Y; Luo X; Jiang W; Su Y; Shen J; Kim SH; Huang E; Gao Y; Zhou JZ; Yang K; Luu HH; Pan X; Haydon RC; Deng ZL; He TC
J Biol Chem; 2010 Sep; 285(38):29588-98. PubMed ID: 20628059
[TBL] [Abstract][Full Text] [Related]
22. Regulation of the ALK1 ligands, BMP9 and BMP10.
Li W; Salmon RM; Jiang H; Morrell NW
Biochem Soc Trans; 2016 Aug; 44(4):1135-41. PubMed ID: 27528761
[TBL] [Abstract][Full Text] [Related]
23. Transforming Growth Factor-β Family Ligands Can Function as Antagonists by Competing for Type II Receptor Binding.
Aykul S; Martinez-Hackert E
J Biol Chem; 2016 May; 291(20):10792-804. PubMed ID: 26961869
[TBL] [Abstract][Full Text] [Related]
24. Bone morphogenetic protein 2 regulates cell-cell communication by down-regulating connexin43 expression in luteinized human granulosa cells.
Wu YT; Chang HM; Huang HF; Sheng JZ; Leung PC
Mol Hum Reprod; 2017 Mar; 23(3):155-165. PubMed ID: 27986931
[TBL] [Abstract][Full Text] [Related]
25. Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis.
Cunha SI; Pardali E; Thorikay M; Anderberg C; Hawinkels L; Goumans MJ; Seehra J; Heldin CH; ten Dijke P; Pietras K
J Exp Med; 2010 Jan; 207(1):85-100. PubMed ID: 20065063
[TBL] [Abstract][Full Text] [Related]
26. BMP9 attenuates occurrence of venous malformation by maintaining endothelial quiescence and strengthening vessel walls via SMAD1/5/ID1/α-SMA pathway.
Li Y; Shang Q; Li P; Yang Z; Yang J; Shi J; Ge S; Wang Y; Fan X; Jia R
J Mol Cell Cardiol; 2020 Oct; 147():92-107. PubMed ID: 32730768
[TBL] [Abstract][Full Text] [Related]
27. Expression of vascular endothelial growth factor is coordinately regulated by the activin-like kinase receptors 1 and 5 in endothelial cells.
Shao ES; Lin L; Yao Y; Boström KI
Blood; 2009 Sep; 114(10):2197-206. PubMed ID: 19506300
[TBL] [Abstract][Full Text] [Related]
28. Insight into Molecular Mechanism for Activin A-Induced Bone Morphogenetic Protein Signaling.
Xie C; Jiang W; Lacroix JJ; Luo Y; Hao J
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899497
[TBL] [Abstract][Full Text] [Related]
29. SnoN facilitates ALK1-Smad1/5 signaling during embryonic angiogenesis.
Zhu Q; Kim YH; Wang D; Oh SP; Luo K
J Cell Biol; 2013 Sep; 202(6):937-50. PubMed ID: 24019535
[TBL] [Abstract][Full Text] [Related]
30. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis.
Scharpfenecker M; van Dinther M; Liu Z; van Bezooijen RL; Zhao Q; Pukac L; Löwik CW; ten Dijke P
J Cell Sci; 2007 Mar; 120(Pt 6):964-72. PubMed ID: 17311849
[TBL] [Abstract][Full Text] [Related]
31. ALK2/ALK3-BMPR2/ACVR2A Mediate BMP2-Induced Downregulation of Pentraxin 3 Expression in Human Granulosa-Lutein Cells.
Bai L; Chang HM; Cheng JC; Chu G; Leung PCK; Yang G
Endocrinology; 2017 Oct; 158(10):3501-3511. PubMed ID: 28977600
[TBL] [Abstract][Full Text] [Related]
32. Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2.
Macías-Silva M; Hoodless PA; Tang SJ; Buchwald M; Wrana JL
J Biol Chem; 1998 Oct; 273(40):25628-36. PubMed ID: 9748228
[TBL] [Abstract][Full Text] [Related]
33. Protein associated with SMAD1 (PAWS1/FAM83G) is a substrate for type I bone morphogenetic protein receptors and modulates bone morphogenetic protein signalling.
Vogt J; Dingwell KS; Herhaus L; Gourlay R; Macartney T; Campbell D; Smith JC; Sapkota GP
Open Biol; 2014 Feb; 4(2):130210. PubMed ID: 24554596
[TBL] [Abstract][Full Text] [Related]
34. Endoglin differentially modulates antagonistic transforming growth factor-beta1 and BMP-7 signaling.
Scherner O; Meurer SK; Tihaa L; Gressner AM; Weiskirchen R
J Biol Chem; 2007 May; 282(19):13934-43. PubMed ID: 17376778
[TBL] [Abstract][Full Text] [Related]
35. Constitutively active ALK2 receptor mutants require type II receptor cooperation.
Bagarova J; Vonner AJ; Armstrong KA; Börgermann J; Lai CS; Deng DY; Beppu H; Alfano I; Filippakopoulos P; Morrell NW; Bullock AN; Knaus P; Mishina Y; Yu PB
Mol Cell Biol; 2013 Jun; 33(12):2413-24. PubMed ID: 23572558
[TBL] [Abstract][Full Text] [Related]
36. Endoglin-mediated suppression of prostate cancer invasion is regulated by activin and bone morphogenetic protein type II receptors.
Breen MJ; Moran DM; Liu W; Huang X; Vary CP; Bergan RC
PLoS One; 2013; 8(8):e72407. PubMed ID: 23967299
[TBL] [Abstract][Full Text] [Related]
37. Homeobox D3, A Novel Link Between Bone Morphogenetic Protein 9 and Transforming Growth Factor Beta 1 Signaling.
Wang L; Yao J; Yu T; Zhang D; Qiao X; Yao Z; Wu X; Zhang L; Boström KI; Yao Y
J Mol Biol; 2020 Mar; 432(7):2030-2041. PubMed ID: 32061928
[TBL] [Abstract][Full Text] [Related]
38. Regulation of bone morphogenetic protein 9 (BMP9) by redox-dependent proteolysis.
Wei Z; Salmon RM; Upton PD; Morrell NW; Li W
J Biol Chem; 2014 Nov; 289(45):31150-9. PubMed ID: 25237187
[TBL] [Abstract][Full Text] [Related]
39. SMAD4 Feedback Activates the Canonical TGF-β Family Signaling Pathways.
Liu L; Li Q; Yang L; Li Q; Du X
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576190
[TBL] [Abstract][Full Text] [Related]
40. Activin receptor-like kinase 7 induces apoptosis through up-regulation of Bax and down-regulation of Xiap in normal and malignant ovarian epithelial cell lines.
Xu G; Zhou H; Wang Q; Auersperg N; Peng C
Mol Cancer Res; 2006 Apr; 4(4):235-46. PubMed ID: 16603637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]